JNVSX
Price
$20.42
Change
-$0.09 (-0.44%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

JNVSX vs VMCPX

Header iconJNVSX vs VMCPX Comparison
Open Charts JNVSX vs VMCPXBanner chart's image
Jensen Quality Value J
Price$20.42
Change-$0.09 (-0.44%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JNVSX vs VMCPX Comparison Chart
Loading...
VS
JNVSX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNVSX is a Buy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. JNVSX (213M). VMCPX pays higher dividends than JNVSX: VMCPX (1.51) vs JNVSX (0.38). JNVSX was incepted earlier than VMCPX: JNVSX (14 years) vs VMCPX (14 years). JNVSX is a more actively managed with annual turnover of: 15.57 vs. VMCPX (13.00). JNVSX has a lower initial minimum investment than VMCPX: JNVSX (2500) vs VMCPX (100000000). JNVSX (25.81) and VMCPX (25.17) have marching annual gain over last year. JNVSX return over 5 years is better than : 60.56 vs. VMCPX (56.93).
JNVSXVMCPXJNVSX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years14 years-
Gain YTD12.69312.593101%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets213M172B0%
Annual Yield % from dividends0.381.5125%
Returns for 1 year25.8125.17103%
Returns for 3 years18.089.85184%
Returns for 5 years60.5656.93106%
Returns for 10 years53.00128.7541%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHR3.060.01
+0.33%
Archer Aviation
SBT4.64-0.02
-0.43%
Sterling Bancorp
EBAY62.75-0.47
-0.74%
eBay
CNXC63.38-0.79
-1.23%
Concentrix Corp
NRBO3.19-0.07
-2.15%
NeuroBo Pharmaceuticals